Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers

The Journal of Clinical Endocrinology and Metabolism
Bernhard M W SchmidtM Wehling

Abstract

T(3) has been shown to exert cardiovascular effects. These effects have not yet been defined with regard to the mode of action (nongenomic vs. genomic) and with regard to an interaction with the adrenergic system in humans. To address these issues we conducted a randomized, double blind, 6-fold cross-over trial in 18 healthy male volunteers. After pretreatment with the beta-agonist dobutamine, the beta-blocking agent esmolol, or placebo (0.9% NaCl), 100 microg T(3) or placebo were injected. Primary target variables were systemic vascular resistance (SVR) and cardiac output (CO) within 45 min after injection of T(3) vs. placebo after placebo pretreatment. Sympatho-vagal balance was assessed by measurement of heart rate variability. T(3) caused a lower SVR and a higher CO than placebo (P < 0.001) after pretreatment with placebo. An increased low frequency (LF)/high frequency (HF) ratio (power in LF/power in HF band) after T(3) compared with placebo (P = 0.004) suggests an increase in sympathetic tone. After pretreatment with dobutamine, the effects of T(3) on SVR and CO were abolished, and the effect on LF/HF ratio was reversed. After pretreatment with esmolol, the effects on SVR and LF/HF ratio were reversed. Our data show, for ...Continue Reading

References

May 1, 1992·Journal of the American College of Cardiology·W H MartinE Korte
Aug 1, 1991·Journal of Molecular Endocrinology·R B LomaxW R Robertson
Oct 26, 1991·Biochimica Et Biophysica Acta·D R HarrisW Craelius
Mar 1, 1989·The Biochemical Journal·H Hummerich, S Soboll
Mar 1, 1989·Journal of Molecular and Cellular Cardiology·J Segal
Mar 1, 1983·The Journal of Clinical Investigation·F B DavisS D Blas
Feb 15, 1984·Archives of Biochemistry and Biophysics·A RudingerS D Blas
Mar 6, 1981·JAMA : the Journal of the American Medical Association·V BacciA C Carter
Nov 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D WalkerF G Spinale
Dec 7, 1995·The New England Journal of Medicine·J D KlempererK Krieger
Jul 1, 1993·The Annals of Thoracic Surgery·W H Dillmann
Aug 1, 1993·Circulation Research·S C Dudley, C M Baumgarten
Nov 1, 1995·Clinical Science·A MallianiF Lombardi
May 1, 1996·The Annals of Thoracic Surgery·J D KlempererK H Krieger
Oct 1, 1996·Thyroid : Official Journal of the American Thyroid Association·P J Davis, F B Davis
Apr 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·R VassyG Y Perret
Jan 1, 1997·Fundamental & Clinical Pharmacology·J ZwavelingP A van Zwieten
Mar 4, 1998·The American Journal of Cardiology·M A HamiltonA Hage
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·B M SchmidtM Wehling
Feb 9, 2000·Frontiers in Neuroendocrinology·B M SchmidtM Wehling

❮ Previous
Next ❯

Citations

Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yukio HiroiJames K Liao
Dec 1, 2009·Vascular Pharmacology·Aaron M Ranasinghe, Robert S Bonser
Jun 1, 2008·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Karol Federico MorenoGabriela Arata-Bellabarba
May 6, 2008·Pharmacology & Therapeutics·Constantinos PantosDennis Cokkinos
Jul 10, 2007·The Veterinary Clinics of North America. Small Animal Practice·Harriet M Syme
Dec 11, 2014·Current Heart Failure Reports·Viswanathan Rajagopalan, A Martin Gerdes
Apr 27, 2016·Heart Failure Reviews·Alice AccorroniRiccardo Zucchi
Aug 28, 2016·Journal of Clinical Laboratory Analysis·Selçuk YazıcıKemal Yeşilçimen
Jan 28, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Paul R CrisostomoDaniel R Meldrum
Nov 16, 2019·Minerva medica·Alessandro P DelitalaGian Luca Erre
Oct 19, 2006·The Journal of Clinical Endocrinology and Metabolism·Raffaele NapoliLuigi Saccà
Feb 7, 2007·Developmental Dynamics : an Official Publication of the American Association of Anatomists·L JiC C Helbing
May 18, 2021·Endocrinology·Daniela GeistLars C Moeller
Aug 16, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Paul J Davis
May 23, 2014·Science Signaling·Hema KalyanaramanRenate B Pilz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.